Start › Niedrobnokomórkowy rak płuca › Illinois › Waukegan
Badania kliniczne dla Niedrobnokomórkowy rak płuca w mieście Waukegan, IL
16 badań dla Niedrobnokomórkowy rak płuca szuka uczestników w ośrodkach w mieście Waukegan i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- AMG Libertyville - Oncology, Libertyville · 8 mi dalej
- Condell Memorial Hospital, Libertyville · 8 mi dalej
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekrutacjaFaza 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi dalej
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi dalej
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- City of Hope Chicago, Zion · 6 mi dalej
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekrutacjaFaza 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi dalej
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi dalej
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi dalej
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Zion · 6 mi dalej
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Research Site, North Chicago · 3 mi dalej
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekrutacjaFaza 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi dalej
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi dalej
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekrutacjaFaza 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mi dalej
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi dalej
- AMG Libertyville - Oncology, Libertyville · 8 mi dalej
- Condell Memorial Hospital, Libertyville · 8 mi dalej
- i 1 więcej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi dalej
- AMG Libertyville - Oncology, Libertyville · 8 mi dalej
- Condell Memorial Hospital, Libertyville · 8 mi dalej
- i 1 więcej
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi dalej
- AMG Libertyville - Oncology, Libertyville · 8 mi dalej
- Condell Memorial Hospital, Libertyville · 8 mi dalej
- i 1 więcej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi dalej
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi dalej
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RekrutacjaFaza 2
- City of Hope at Chicago, Zion · 6 mi dalej
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- AMG Libertyville - Oncology, Libertyville · 8 mi dalej
- Condell Memorial Hospital, Libertyville · 8 mi dalej
Badania dla Niedrobnokomórkowy rak płuca w innych miastach
- Houston, TX145 badań
- New York City, NY121 badań
- Arlington, VA104 badań
- Nashville, TN97 badań
- Boston, MA90 badań
- Los Angeles, CA87 badań
- St. Louis, MO73 badań
- Chicago, IL61 badań
- Baltimore, MD60 badań
- San Antonio, TX59 badań
- Columbus, OH57 badań
- Washington, DC55 badań
Inne badania w mieście Waukegan
- Rak płuc16 badań
- Rak piersi12 badań
- Wrzodziejące zapalenie jelita grubego7 badań
- Rak nerki (rak komórek nerkowych)7 badań
- Rak jajnika6 badań
- Nowotwór przerzutowy6 badań
- Rak płaskonabłonkowy głowy i szyi6 badań
- Rak jelita grubego i odbytnicy6 badań
- Rak prostaty6 badań
- Czerniak5 badań
- Ostra białaczka szpikowa5 badań
- Choroba Leśniowskiego-Crohna5 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.